46 results about "Headaches" patented technology

An integrated medical platform with system and methods for enhancing medical procedures by rapid-data integration, artificial intelligence (“AI”) analyses with real-time, data-driven insights generated by machine learning models, which are executed in real time and continuously evolving to assist medical professionals in providing favorable outcomes. Other aspects of the integrated medical platform are configured to improve quality of procedures, automate regulatory headaches and streamline clinical coordination to improve outcomes and cost. In some embodiments, a unified tracking system is configured to track TAVR procedures introduces hospitals to an integrated, multimodal AI-enabled platform designed as an all-in-one platform configured to improve planning and care coordination of complex procedures. Smart data collection optimizes billing and streamlines registry data capture. It provides predictive clinical guidance powered by privacy-preserving federated deep learning and generative AI improves patient care.

Disclosed herein are pharmaceutical compositions, devices, their combinations, and their uses thereof for example in treating or preventing headaches.

1. The name of this design product: Wrist-worn headache treatment device. 2. Purpose of this design product: used to treat and prevent headaches. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model.

The present disclosure relates to use of artemin inhibitors in prevention or treatment of headaches such as migraine.

A system may include one implantable pulse generator and at least one implantable lead. The pulse generator may include a processor, a driving system for driving electrodes, a communication circuit, and a housing configured to be subcutaneously implanted. The lead may be configured to extend from the pulse generator to at least one neural target on a left side of a head and a neural target on a right side of the head. The lead may include at least two electrode sets, each including at least two electrodes. The lead be configured to be used to subcutaneously place the at least two electrode sets near the at least two neural targets, respectively, and electrically connect the pulse generator to each of the at least two electrodes sets to enable the driving system to drive the at least two electrode sets to stimulate the at least two neural targets.

This invention discloses an environmental parameter sensing and adaptive adjustment system and method based on a photoconductive film. It integrates six-dimensional environmental sensors—light intensity, ultraviolet radiation, temperature, humidity, air pressure, and air quality—at the edge of the photoconductive film, and utilizes the film's directional light guidance and stray light filtering mechanisms to reduce environmental interference. The system includes an environmental sensing module, an environmental parameter processing module, a health data interface module, a correlation analysis module, an adaptive adjustment module, and an environmental early warning module. The correlation analysis module has preset environmental-health correlation patterns such as low temperature-increased blood pressure, high humidity-decreased blood oxygen, high ultraviolet radiation-skin health, poor air quality-respiratory diseases, and sudden changes in air pressure-headaches and joint pain, set based on clinical research data. The adaptive adjustment module pairs with smart home devices through a unified identity authentication center, sending control commands via Wi-Fi / Bluetooth / infrared to automatically adjust air conditioners, humidifiers, dehumidifiers, air purifiers, and lighting according to environmental parameters. The environmental early warning module supports single-indicator early warning, correlation early warning, trend early warning, and seasonal disease early warning, with customizable thresholds. The multi-environmental data fusion module uses weighted averaging and the 3σ principle for anomaly removal, integrating data from multiple devices such as mobile phones, watches, vehicles, and smart home devices. The sensors are automatically calibrated daily using meteorological bureau data, with the calibration process simultaneously linked to health data. This invention solves the problems of scattered environmental sensing devices, disconnect from health data, and inability to proactively adjust, serving as the infrastructure for intelligent health management.

The invention discloses a making method of a gastrodia elata tea bag in the technical field of tea drink making. The making method comprises the following steps: S1, weighing raw materials; s2, raw material treatment; s3, equally dividing the raw materials; s4, sub-packaging and sealing bags; and S5, packaging. According to the tea bag, gastrodia elata is used as a main raw material, the tea bag has the effects of resisting rheumatism, calming, tonifying deficiency, calming the liver and calming endogenous wind, radix salviae miltiorrhizae, radix cyathulae and uncaria are added, gastrodia elata is matched with the radix salviae miltiorrhizae, radix cyathulae and uncaria, the effects of tonifying qi, activating blood circulation and reducing blood pressure can be improved, and headache, dizziness, insomnia and the like can be relieved; the effects of tonifying liver and kidney, strengthening muscles and bones, dredging blood vessels and enhancing the tea bag are achieved; compared with a medicated diet mode and the like, the teabag is more convenient to use, can be directly used, reduces the operations of weighing, subpackaging and the like when a tea drinker uses the teabag, avoids the situations of excessive drinking and the like, and is safer and suitable for daily life.

A method of treating a headache, e.g., a migraine, in a subject is provided. The method comprises administering a preparation comprising ammonia oxidizing microorganisms to the subject, thereby treating the headache. Related preparations, kits, and devices are also provided.

1. The name of this design product: electric powder cap. 2. Purpose of this design product: An electric medicine cap that can hold Chinese medicine bags to relieve symptoms such as headaches and dizziness. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The present invention relates to a food composition for preventing or alleviating osteoporosis, the food composition containing a propolis bioconversion extract as an active component. The present invention can provide a food composition for preventing or alleviating osteoporosis, wherein the food composition can be easily and simply prepared and has an excellent osteoporosis prevention effect. In addition, the present invention can provide a food composition for preventing or alleviating osteoporosis, wherein side effects such as weight gain or headaches due to long-term ingestion can be minimized.

A system may include one implantable pulse generator and at least one implantable lead. The pulse generator may include a processor, a driving system for driving electrodes, a communication circuit, and a housing configured to be subcutaneously implanted. The lead may be configured to extend from the pulse generator to at least one neural target on a left side of a head and a neural target on a right side of the head. The lead may include at least two electrode sets, each including at least two electrodes. The lead be configured to be used to subcutaneously place the at least two electrode sets near the at least two neural targets, respectively, and electrically connect the pulse generator to each of the at least two electrodes sets to enable the driving system to drive the at least two electrode sets to stimulate the at least two neural targets.

A therapeutic device and method for using the same. The therapeutic device has a supportive body and a pressure applicator extending from the body that is configured to apply pressure to suboccipital muscles of a patient. The pressure applicator may be altered to adjust a position and points through which to apply pressure to the suboccipital muscles. The body may be positioned at an angle relative to the patient's neck and the pressure applicator is applied to the suboccipital muscles. The pressure can be applied for a duration of time to relieve and / or prevent headaches and migraines in patients.

The present invention discloses a Baizhi bead health product and a preparation method thereof. The Baizhi bead health product comprises Baizhi beads formed by grinding Baizhi roots and a protective layer coated on the surface of the Baizhi beads; the protective layer is a porous polymer composite material composed of graphene oxide-modified silica, epoxy resin, a curing agent, and nitrile rubber. The Baizhi bead health product directly forms the Baizhi root into a bead-shaped body and coats the surface of the bead with a protective layer. This avoids the problem of rapid volatilization of Baizhi volatile oil caused by grinding the Baizhi, and has health benefits such as relieving headaches, allergic rhinitis, and preventing viruses. It also reduces the probability of Baizhi being easily scratched or damaged due to its soft texture, allowing the Baizhi beads to be worn for long periods of time, achieving long-term and effective health benefits.

This disclosure relates to heterocyclic compounds of Formula (I) as well as the preparation and use thereof. As contemplated herein, heterocyclic compounds of Formula (I) can be any one of a carbohydrate conjugate and an amino acid conjugate. The heterocyclic compounds of Formula (I) may be used for the treatment of neuropsychiatric, and neurodegenerative, neuroinflammatory and pain disorders including depression, as well as tobacco, opiate, and cocaine addiction, alcoholism, post-traumatic stress disorder (PTSD), and pain syndromes including cluster headaches and chemotherapy induced peripheral neuropathy.

The utility model provides an intelligent pillow inner with a massage function, and belongs to the technical field of intelligent pillow inner. Comprising a pillow inner body, the filling layer is arranged in the pillow inner body; the head massage area is arranged in the pillow inner body; the two neck massage air bags are arranged in the pillow inner body; the two shoulder massage air bags are arranged in the pillow inner body. By arranging the small air bags, the head can be massaged, by means of regular massage of the small air bags, nervous tension and pressure of the head can be effectively relieved, symptoms such as headache and dizziness can be improved, mental fatigue after one-day fatigue is relieved, and by arranging the neck massage air bag and the shoulder massage air bags, the head can be massaged through the neck massage air bag and the shoulder massage air bag. The neck and the shoulders of a user can be massaged, deep massage is carried out on neck muscles and shoulder muscles which often bear pressure, the problems of cervical vertebra pain, scapulohumeral periarthritis and the like are solved, meanwhile, blood circulation is promoted, and muscle stiffness and pain are relieved.

The utility model discloses a wearable device for treating or preventing headache, which comprises a stimulator and a flexible fixing piece connected with the stimulator, and the flexible fixing piece can fix the stimulator on a wrist, a head or an upper arm; the first electrode is used for targeting wrist nerves on the wrist, and the stimulator is configured to provide electrical stimulation for the wrist nerves on the wrist through the first electrode; the second electrode is used for targeting frontal nerves of the head or sensory nerve C-type fibers on the upper arms, and the stimulator is configured to provide electrical stimulation for the frontal nerves of the head or the sensory nerve C-type fibers on the upper arms through the second electrode; the wearable device can be worn on the wrist, the head or the upper arm, so that a patient can freely select the wearing position according to the current use occasion and preference, the use requirements of the patient in various use scenarios can be met, the wearable device is convenient to carry daily, the use convenience of the headache treatment instrument is greatly improved, and more choices are provided for a user.

The invention discloses a real-time rendering naked eye three-dimensional display system using a visual identification eye tracking algorithm. The system comprises the following subsystems: 1) naked eye three-dimensional display equipment with an image acquisition device; 2) an image receiving module for receiving output information of the image acquisition module; (3) an image information processing module obtains two-dimensional pixel coordinates of the pupil center point of the viewer; (4) a space positioning module obtains three-dimensional space coordinates of pupils of the observer and a gazing direction vector of the observer; and 5) the information output rendering module performs viewpoint arrangement on the three-dimensional display content again, and finally renders and outputs the target image to the display equipment according to the input requirement of the three-dimensional display equipment. According to the invention, the use cost of an eye tracking and three-dimensional display system is greatly reduced, and meanwhile, the requirements that visual images are coherent and a viewer does not feel dizziness, headache and visual fatigue after watching for a long time are effectively met.

The subject matter described herein relates to a series of orthopedic and hotel pillows that will reduce neck pain, headaches, help with TMJ symptoms, inhibit snoring, improve cervical spine neutrality, and assist in shoulder support while sleeping. The pillows are customized for the consumer using quantifiable scientific data resulting in proper cervical alignment when sleeping. The claimed system removes any guess-work associated with purchasing pillows and reduces customer dissatisfaction, improves comfort and reduces pain and injury. The claimed material of the pillows also combats microbes and fungi.

A preparation comprising the YEL002 compound as an active ingredient for the prevention or treatment of one or more diseases, and methods of using such preparations. The preparations may be a sublingual pill, an injection, dissolved in liquid, dissolved in oil, or any other preparation. The conditions or diseases indicated may be poisoning, radiation poisoning, chemotherapy poisoning, poor vision, peripheral artery disease, smoker's leg, diabetic feet, periodontal disease, varicose or spider veins, blood clots, COVID-19, long COVID, liver disease, symptoms caused by chemotherapy or radiation therapy, hair loss, cancer, inflammation-caused or inflammation-related diseases, autoimmune diseases, infections, and headaches including migraines.

This article discloses a lipid prodrug of bromo-lysergic acid diethylamide (2-bromo-LSD) (2-bromo-lysergic acid diethylamide), which achieves improved pharmacokinetic properties and allows for easier long-term administration to patients. The disclosed lipid prodrug is indicated for the treatment of cluster headaches and mood disorders in human subjects.

The present invention belongs to the technical field of materials, and provides a biological mineral crystal material and a preparation method therefor, and a sleep-aiding tech pillow. The preparation method comprises: modifying the surface of a natural mineral crystal, then mixing same with doped TiO2 / Fe3O4-intercalated montmorillonite to prepare a crystal powder modified by the doped TiO2 / Fe3O4-intercalated montmorillonite, modifying the surface thereof by using polydopamine, allowing same to adsorb an aromatic essential oil, and encapsulating same in sodium alginate, so as to prepare a spherical biological mineral crystal material. The tech pillow prepared by adding the biological mineral crystal material prepared in the present invention can slowly release essential oil molecules, thereby improving the durability thereof; moreover, spherical particles facilitate the stimulation of acupuncture points, which is conducive to improving sleep quality; in addition, by releasing infrared waves, forming a magnetic field and releasing anions into the surrounding environment, the pillow purifies organic pollutants, formaldehyde, etc., in the air, improves the quality of indoor air, alleviates symptoms such as headaches and insomnia, and thus has wide application prospects.

A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.

This disclosure relates to heterocyclic compounds of Formula (I). As contemplated herein, heterocyclic compounds of Formula (I) may be used for the treatment of neuropsychiatric, and neurodegenerative, neuroinflammatory and pain disorders including depression, as well as tobacco, opiate, and cocaine addiction, alcoholism, post-traumatic stress disorder (PTSD), and neuropathic pain syndromes including cluster headaches and chemotherapy induced peripheral neuropathy.

The invention discloses a 5-hydroxytryptophan crystal form as well as a preparation method and application thereof, and belongs to the technical field of medical products. In a powder X-ray diffraction pattern of the 5-hydroxytryptophan crystal form, characteristic peaks exist at 2theta diffraction angles of 8.1 + / -0.2 degrees, 10.5 + / -0.2 degrees, 12.7 + / -0.2 degrees, 14.0 + / -0.2 degrees, 17.7 + / -0.2 degrees, 18.9 + / -0.2 degrees, 20.2 + / -0.2 degrees, 21.3 + / -0.2 degrees, 22.0 + / -0.2 degrees, 23.2 + / -0.2 degrees, 24.7 + / -0.2 degrees, 25.7 + / -0.2 degrees, 29.4 + / -0.2 degrees, 31.5 + / -0.2 degrees and 32.5 + / -0.2 degrees. The preparation process of the novel crystal form of 5-hydroxytryptophan is simple to operate, low in energy consumption, high in economical efficiency and high in reproducibility. The product has good chemical stability, the yield is 90% or above, and the purity reaches 99.5% or above. The compound has a good application prospect in preparation of products with better stability for resisting depression, losing weight, reducing blood pressure, preventing headache or relieving insomnia.

The technical field that this invention pertains to is pharmaceuticals. The problem that this invention solves is that current over-the-counter migraine / headache medications only treat one symptom which is pain, and current over-the-counter flu products do not address nausea or vomiting which are the most debilitating symptoms of the stomach flu. This invention solves those aforementioned gaps in the market with the addition of an antiemetic to address nausea, vomiting, vertigo, and vestibular symptoms associated with migraines or headaches and the stomach flu. Consumers with migraines or headaches would use this invention if their symptoms included pain, nausea, vomiting, vertigo, or any other vestibular symptoms such as phonophobia or photophobia. Consumers with the stomach flu would use this invention if their symptoms included any of the usual flu symptoms such as fever, pain, body aches, but also with nausea and vomiting which is the key difference compared to existing flu products currently on the market. This invention is new because no prior art discusses using any antiemetics by themselves as a single entity medication or in combination with an analgesic(s) including but not limited to: (1) acetaminophen with or without caffeine and with or without aspirin, (2) acetaminophen with ibuprofen; (3) acetaminophen with naproxen, (4) aspirin, (5) naproxen, and (6) ibuprofen; (7) ketorolac; for the indication of nausea with or without vomiting; vertigo such as migraine-associated vertigo, photophobia, phonophobia, and with or without pain. Additionally, this invention also differs from prior art in that antiemetics can be used in any combination with the aforementioned analgesic(s), and are also able to combined with or without a nasal decongestant such as phenylephrine including any newly reformulated version(s ) of phenylephrine and / or pseudoephedrine with or without dextromethorphan hydrobromide or dextromethorphan polistirex; and with or without guaifenesin. The interchangeability of the drugs and doses allows for versatility which prior art does not offer. Actual dosages used will be within that range at therapeutic, efficacious, and safe dosages in said subjects for the treatment of the indication(s) being claimed and / or exhibited by said subjects at appropriate dosing intervals. Utilizing subtherapeutic and supratherapeutic doses in the ranges are not obvious or usual doses utilized by a person knowledgeable in the prior art, therefore differentiating it from prior art and supporting patentability.

This invention relates to the field of intelligent control technology for medical devices, and provides a device for monitoring and relieving headache abnormalities through stimulation intervention. The device includes a helmet-shaped main frame housing a monitoring and relief module; an intelligent control system that asynchronously collects physiological characteristics and hardware load status via a duplex channel, deriving a high-dimensional state fusion model; and a closed-loop evaluation and iteration module to establish a differential efficacy closed-loop mechanism, uploading the collected data to the cloud for storage, enabling historical data management, clinical analysis, and continuous optimization of personalized strategies. This technical solution addresses the problems of dependence and side effects associated with traditional drug treatments, the high trauma and cost of surgical treatments, and the tendency of existing migraine intervention devices to develop tolerance in the nervous system due to fixed and predictable stimulation parameters used in open-loop control, leading to gradual attenuation of intervention effects over time and an inability to provide personalized and precise treatment.

To provide a pharmaceutical product useful for the treatment or prevention of opioid δ receptor-related diseases. [Solution] The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exerts opioid δ receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid δ receptor-related diseases (e.g., headaches) may be treated or prevented.

The invention relates to a therapeutic headband designed to relieve headaches, migraines, and tension through targeted pressure application. The headband applies pressure to acupressure points along the temples and the area in front of the ears, areas commonly associated with headache relief. The headband is worn comfortably around the head, with adjustable features that allow users to customize the pressure applied to each point.

1. Name of the product in this design: Wrist-worn headache treatment device. 2. Purpose of this design: for the treatment and prevention of headaches. 3. The key design point of this design product lies in the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model.

The present disclosure provides a method of identifying and / or quantifying a perceived immune fitness of an individual. The method comprises identifying a frequency and / or a severity of one or more conditions experienced by an individual. The one or more conditions includes sore throat, headaches, flu, runny nose, coughing, cold sores, boils, mild fever, warts, pneumonia, bronchitis, sinusitis, sudden high fever, ear infection, diarrhea, meningitis, eye infection, sepsis, long healing injuries, shortness of breath, skin problems, muscle and joint pain, and common cold. The method further includes calculating a perceived immune fitness score of the individual based on up to 10 of the one or more conditions with the highest frequency and / or severity.